http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9222279-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-13 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-13 |
| filingDate | 1992-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4b5cb5bd7d76e792c475983a7a782b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1659ca8ffa158fb79e49ffb7b805089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b8f74a02c9587a1af361e31878e3b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60405585d1e2407768a7ad1792c0e30e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef62b82145a90cbf96086c214092036e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5174f6f811e4cfc5d74121871ac117b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_541c5668364ff9cea2706ce80a7f2656 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4474bfdc4283e8ca23cffb6b801f0ca2 |
| publicationDate | 1992-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9222279-A2 |
| titleOfInvention | N-[arylethyl]-n-alkyl-2-(1-pyrrolidinyl)ethylamine derivatives for cns disorders |
| abstract | Certain N-[arylethyl]-N-alkyl-2-(1-pyrrolidinyl)-ethylamine compounds are described for treatment of CNS disorders such as cerebral ischemia, psychotic disorders, convulsions and parkinsonism. Compounds of particular interest are of formula (I) wherein R1 is selected from hydrido, loweralkyl, cycloalkylalkyl of four to six carbon atoms and loweralkenylloweralkyl; wherein each of R?2 and R3¿ is independently selected from hydrido and loweralkyl; wherein each of R4 through R9 is independently selected from hydrido, hydroxy, loweralkyl, benzyl, phenoxy, benzyloxy and haloloweralkyl; wherein m is a number selected from one through three; wherein n is a number selected from four through seven; wherein p is a number selected from zero through four; wherein A is selected from phenyl, naphthyl and thienyl; wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from hydrido, hydroxy, loweralkyl, loweralkoxy, halo, haloloweralkyl, amino, monoloweralkylamino and diloweralkylamino; or a pharmaceutically acceptable salt thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017521392-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844008-B2 |
| priorityDate | 1991-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 265.